echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > A drop of up to 80%! Hengrui Pharmaceutical/Kelun Pharmaceutical Sodium Bicarbonate Ringer Injection Reduces Prices at the Same Time

    A drop of up to 80%! Hengrui Pharmaceutical/Kelun Pharmaceutical Sodium Bicarbonate Ringer Injection Reduces Prices at the Same Time

    • Last Update: 2020-05-28
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Pharmaceutical Network On May 22nd, only two pharmaceutical companies are on the market with the injection of bicarbonate of sodium, and only one year on the market, both of which have reduced prices at the same time, by as much as 80%Recently, Heilongjiang Provincial Health Insurance Bureau issued a notice, received Jiangsu Hengrui Pharmaceutical Co., Ltd., Sichuan Colum Pharmaceutical Co., Ltdand otherof the initiative to reduce prices, Hengrui's bicarbonate sodium gingling injection (500ml) fell 72.5 percent from 357.25 yuan to 98 yuan, and Gaba Spray Capsules (0.1g) fell from 25.41 yuan to 24.46 yuanis worth noting that when Hengrui's bicarbonate of sodium bicarbonate injection sachets were significantly reduced, Sichuan Collum's bicarbonate-sodium-ringing injection also dropped in sync, 500ml of a bag of specifications from 363 yuan to 64 yuan, a drop of up to 82%;In addition, Sanofi's Gremmel tablets (2mg, 15 tablets/box) were reduced from 64.3 yuan to 49.28 yuanIt is understood that the bicarbonate of sodium ringer injection for a compound electrolyte injection, used in the circulation of blood and tissue fluid reduction (such as perioperative period, etc.), as a supplementary regulator of extracellular fluid, to correct metabolic acidosisThe sodium bicarbonate injection was originally developed in Otsuka, Japan, and was approved for sale in Japan in 2010The variety can improve metabolic acidosis quickly and effectively, and has obvious effect in maintaining acid-base balance and electrolyte balancethe product, currently approved with the same specifications only 2 enterprises, for Hengrui Pharmaceuticals and Colum PharmaceuticalsBoth enterprises have declared a consistency evaluation, and the status is currently in the review and approvalaccording to thedata, Hengrui Pharmaceuticals' bicarbonate sodium ringer injection signed a registration application with the State Drug Administration in January 2015, and received the approved "New Drug Certificate" and "
    Registration Approval" in April 2019, which approved the listing of bicarbonate sodium-ringing injection, which was the first comparable listing in China;that is, the variety is on the market only two pharmaceutical companies on the market, and basically only a year in the market, two products at the same time significantly reduced prices, down by as much as 80%   On April 24, Shaanxi Provincial Public Resources Trading Center announced that Jiangsu Hengrui bicarbonate sodium Ringer injection (drug number: 8215982, specification: 500ml /bag) hanging network limit price adjusted from 295 yuan to 98 yuan   Hengrui's reason for the price reduction comes from the March 31 Colum related action - March 31, Collum took the lead in Shaanxi Province pharmaceutical concentrated platform to take the initiative to reduce prices, 500ml / bag of products from 238 yuan to 64 yuan, 1000ml / bag of product scoping from 498.1 yuan to 108.8 yuan late May, Colum and Hengrui's price cuts extended to the Heilongjiang market, and it is expected that under the trend of price linkage, the provinces will hear the price reduction news of this variety meters net data show that in 2019, the variety in China's urban public terminal sales reached 3.23 million yuan, from the quarterly sales, Q2 sales in 2019 is only 230,000 yuan, Q3 in 2019 to 470,000 yuan, an increase of 103.35 percent, to 2019 Q4, to achieve rapid release volume, growth of up to 2.52 million yuan, a growth rate of up to 436.17% the product in the domestic market showed a fairly rapid release speed, the future has a larger market space industry has a view that the market space of bicarbonate sodium ringer injection is more than 1 billion, but also Hengrui sodium potassium magnesium calcium glucose injection (commodity name: Lega) upgrade products, the future there is the possibility of replacing the Lega market In 2018, sales of henri sodium potassium magnesium calcium glucose injections will be about 28 million bags, and if sodium bicarbonate is replaced by one-tenth of the market, annual sales could reach 2.8 million bags when only two listings were available, Hengrui and Collum cut prices by nearly 80% at the same time, putting greater price pressure on the late competitors and helping both to seize the market in fact, with the arrival of a new round of national collection and health insurance talk, the health insurance fund cage-for-bird speed and become normal, price reduction has become the main theme, whether or not consistency evaluation, whether it is the original research drug, we have to face the risk of price reduction, which has become the industry consensus the function of generic drugs has also changed, from profit-making to brand expansion, channel laying, word-of-mouth, contribution to stable cash flow conversion on the one hand, under the pressure of a series of new policies, the competition for mature products (patent expired original sass and generics) has reached a critical point; and for each of the medical people in the depths, how to find the most suitable and least risky products according to the market share, sales, production capacity, API production, penetration rate and substitution rate, etc is the topic that needs to be studied at present.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.